Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Carissa Baker-Smith

Pediatric Cardiology Wilmington, DE Medical Doctor

NPI 1508031121 CMS profile 605298

1600 Rockland Rd, Wilmington, DE 19803

Open in the dashboard

General payments

$4,583

15 records reported · program years 2019–2025

Research payments

$3,054

Paid to them · 7 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$136,137 paid to institutions, not to them · program years 2019–2023

Through program year 2025, Carissa Baker-Smith of Wilmington, DE is reported in the CMS Open Payments database as having received $4,583 across 15 general payments and $3,054 in research payments paid to them. Separately, studies naming them as principal investigator received $136,137 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 89th percentile of Pediatric Cardiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $4,249 8
2024 Research $472 2
2023 General $137 1
2023 Research $2,581 5
2022 General $66 2
2021 General $91 2
2019 General $39 2

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Carissa Baker-Smith
  • Pediatric Cardiology median
  • Middle half of Pediatric Cardiology
  • National median

In program year 2025, general payments to Carissa Baker-Smith were reported at $4,249. Among 1,168 Pediatric Cardiology profiles paid that year, the median was $146 and the middle half received between $47 and $670.

Show as a table
Year Carissa Baker-Smith Pediatric Cardiology median Middle half National median
2019 $39 $124 $35–$516 $163
2020 $0 $70 $23–$326 $114
2021 $91 $112 $27–$445 $132
2022 $66 $129 $36–$680 $149
2023 $137 $149 $38–$826 $160
2024 $0 $131 $37–$652 $164
2025 $4,249 $146 $47–$670 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Merck Sharp & Dohme Corporation $4,185 6 payments
  2. Regeneron Pharmaceuticals, Inc. $137 1 payment
  3. Esperion Therapeutics, Inc. $91 2 payments
  4. Abbott Laboratories $48 1 payment
  5. Boston Scientific Corporation $37 1 payment
  6. ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $27 1 payment
  7. Preventice Services, LLC $20 1 payment
  8. Alexion Pharmaceuticals, Inc. $19 1 payment
  9. Philips Electronics North America Corporation $19 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $3,490 2 payments
  2. Travel and Lodging $545 3 payments
  3. Food and Beverage $457 8 payments
  4. Education $91 2 payments
Products named General payments · program years 2019–2025
  1. EVKEEZA $137 1 payment
  2. NEXLETOL $91 2 payments
  3. THORATEC HEARTMATE 3 LVAS IMPLANT KIT $48 1 payment
  4. Baylis Medical Company Radiofrequency Puncture Generator $37 1 payment
  5. LifeVest $27 1 payment
  6. Kanuma $19 1 payment
  7. (5044) MCOT $19 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Regeneron Pharmaceuticals, Inc. $3,054 7 payments

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

19

Median for Cardiology: 2,533

Drug cost

$6,604

Median for Cardiology: $485,213

Branded share of claims

100%

Median for Cardiology: 25.7%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Entresto Sacubitril/Valsartan Brand 19 $6,604

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,782 Part D prescribers listed as Cardiology; they describe a distribution and say nothing about conduct.

Records

22 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Pediatric Cardiology in Delaware

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record